These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 15730353

  • 21. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 22. Progesterone effects on cocaine use in male cocaine users maintained on methadone: a randomized, double-blind, pilot study.
    Sofuoglu M, Poling J, Gonzalez G, Gonsai K, Oliveto A, Kosten TR.
    Exp Clin Psychopharmacol; 2007 Oct; 15(5):453-60. PubMed ID: 17924779
    [Abstract] [Full Text] [Related]

  • 23. Efficacy and tolerability of solifenacin in elderly subjects with overactive bladder syndrome: a pooled analysis.
    Wagg A, Wyndaele JJ, Sieber P.
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):14-24. PubMed ID: 16730617
    [Abstract] [Full Text] [Related]

  • 24. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
    Woods SW, Gueorguieva RV, Baker CB, Makuch RW.
    Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
    [Abstract] [Full Text] [Related]

  • 25. A pilot trial of gepirone vs. placebo in the treatment of cocaine dependency.
    Jenkins SW, Warfield NA, Blaine JD, Cornish J, Ling W, Rosen MI, Urschel H, Wesson D, Ziedonis D.
    Psychopharmacol Bull; 1992 Sep; 28(1):21-6. PubMed ID: 1609038
    [Abstract] [Full Text] [Related]

  • 26. Effects of varying the monetary value of voucher-based incentives on abstinence achieved during and following treatment among cocaine-dependent outpatients.
    Higgins ST, Heil SH, Dantona R, Donham R, Matthews M, Badger GJ.
    Addiction; 2007 Feb; 102(2):271-81. PubMed ID: 17222282
    [Abstract] [Full Text] [Related]

  • 27. A multisite, double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of vigabatrin for treating cocaine dependence.
    Somoza EC, Winship D, Gorodetzky CW, Lewis D, Ciraulo DA, Galloway GP, Segal SD, Sheehan M, Roache JD, Bickel WK, Jasinski D, Watson DW, Miller SR, Somoza P, Winhusen T.
    JAMA Psychiatry; 2013 Jun; 70(6):630-7. PubMed ID: 23575810
    [Abstract] [Full Text] [Related]

  • 28. A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of cocaine dependence.
    Johnson BA, Roache JD, Ait-Daoud N, Javors MA, Harrison JM, Elkashef A, Mojsiak J, Li SH, Bloch DA.
    Drug Alcohol Depend; 2006 Oct 01; 84(3):256-63. PubMed ID: 16631323
    [Abstract] [Full Text] [Related]

  • 29. A double-blind, placebo-controlled trial of modafinil for cocaine dependence.
    Dackis CA, Kampman KM, Lynch KG, Pettinati HM, O'Brien CP.
    Neuropsychopharmacology; 2005 Jan 01; 30(1):205-11. PubMed ID: 15525998
    [Abstract] [Full Text] [Related]

  • 30. A medication screening trial evaluation of reserpine, gabapentin and lamotrigine pharmacotherapy of cocaine dependence.
    Berger SP, Winhusen TM, Somoza EC, Harrer JM, Mezinskis JP, Leiderman DB, Montgomery MA, Goldsmith RJ, Bloch DA, Singal BM, Elkashef A.
    Addiction; 2005 Mar 01; 100 Suppl 1():58-67. PubMed ID: 15730350
    [Abstract] [Full Text] [Related]

  • 31. A randomized, controlled, pilot trial of methylphenidate and cognitive-behavioral group therapy for cocaine dependence in heroin prescription.
    Dürsteler-MacFarland KM, Farronato NS, Strasser J, Boss J, Kuntze MF, Petitjean SA, Bürki C, Wiesbeck GA.
    J Clin Psychopharmacol; 2013 Feb 01; 33(1):104-8. PubMed ID: 23277248
    [Abstract] [Full Text] [Related]

  • 32. Effects of the combination of metyrapone and oxazepam on cocaine craving and cocaine taking: a double-blind, randomized, placebo-controlled pilot study.
    Kablinger AS, Lindner MA, Casso S, Hefti F, DeMuth G, Fox BS, McNair LA, McCarthy BG, Goeders NE.
    J Psychopharmacol; 2012 Jul 01; 26(7):973-81. PubMed ID: 22236504
    [Abstract] [Full Text] [Related]

  • 33. Research issues related to development of medications for treatment of cocaine addiction.
    Klein M.
    Ann N Y Acad Sci; 1998 May 30; 844():75-91. PubMed ID: 9668666
    [Abstract] [Full Text] [Related]

  • 34. A randomized double-blind study of carbamazepine in the treatment of cocaine abuse.
    Halikas JA, Crosby RD, Pearson VL, Graves NM.
    Clin Pharmacol Ther; 1997 Jul 30; 62(1):89-105. PubMed ID: 9246023
    [Abstract] [Full Text] [Related]

  • 35. A double-blind placebo-controlled pilot study of risperidone for decreasing cue-elicited craving in recently withdrawn cocaine dependent patients.
    Smelson DA, Williams J, Ziedonis D, Sussner BD, Losonczy MF, Engelhart C, Kaune M.
    J Subst Abuse Treat; 2004 Jul 30; 27(1):45-9. PubMed ID: 15223093
    [Abstract] [Full Text] [Related]

  • 36. Effects of progesterone treatment on cocaine responses in male and female cocaine users.
    Sofuoglu M, Mitchell E, Kosten TR.
    Pharmacol Biochem Behav; 2004 Aug 30; 78(4):699-705. PubMed ID: 15301924
    [Abstract] [Full Text] [Related]

  • 37. Mazindol for relapse prevention to cocaine abuse in methadone-maintained patients.
    Margolin A, Avants SK, Kosten TR.
    Am J Drug Alcohol Abuse; 1995 Nov 30; 21(4):469-81. PubMed ID: 8561098
    [Abstract] [Full Text] [Related]

  • 38. A placebo-controlled screening trial of olanzapine, valproate, and coenzyme Q10/L-carnitine for the treatment of cocaine dependence.
    Reid MS, Casadonte P, Baker S, Sanfilipo M, Braunstein D, Hitzemann R, Montgomery A, Majewska D, Robinson J, Rotrosen J.
    Addiction; 2005 Mar 30; 100 Suppl 1():43-57. PubMed ID: 15730349
    [Abstract] [Full Text] [Related]

  • 39. Do patient characteristics and initial progress in treatment moderate the effectiveness of telephone-based continuing care for substance use disorders?
    McKay JR, Lynch KG, Shepard DS, Morgenstern J, Forman RF, Pettinati HM.
    Addiction; 2005 Feb 30; 100(2):216-26. PubMed ID: 15679751
    [Abstract] [Full Text] [Related]

  • 40. Phenytoin in the treatment of cocaine abuse: a double-blind study.
    Crosby RD, Pearson VL, Eller C, Winegarden T, Graves NL.
    Clin Pharmacol Ther; 1996 Apr 30; 59(4):458-68. PubMed ID: 8612392
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.